WATCH: Learn how sponsors reduce complexity and manage their drug development challenges to optimize the supply chain, maintain flexibility and ensure the critical success of bringing highly specialized medicines to patients in need.
A panel of experts from PCI Pharma Services and three Life Sciences companies discuss challenges and opportunities related to the development, clinical phases and commercialization of biologics, offering insights on how to improve sponsor-CDMO
As the EU Clinical Trials Regulation (CTR) No 536/2014 go-live date approaches, this chat looks in more detail at some of the pros and cons of the Regulation.
The patient’s ability to use the packaging is based on information we receive. The patient is at the centre throughout the entire design process and their ability to use the product.
How can drug manufacturers utilize all this stability testing data to ensure shelf life? Anna Thabit-Jones, Stability Manager at PCI Services addresses key points around the process
In this recording, we team up with Abby Stephen’s of Suvoda, an industry-leading IRT supplier focusing on complex patient randomization and clinical supply chain challenges.
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Start your PCI experience today.Your bridge between life-changing therapies and patients.
